Cargando…

T223. REAL WORLD EFFECTIVENESS OF ANTIPSYCHOTIC DRUGS IN PATIENTS WITH SCHIZOPHRENIA: A 10-YEARS RETROSPECTIVE STUDY

BACKGROUND: Discontinuation of antipsychotics in patients with schizophrenia has increasing attention as a representative treatment effectiveness of the medication. The objective of present study is to determine which antipsychotic medication is highly effective in a real-world clinical setting cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Tae Young, Kim, Minah, Lee, Junhee, Kwon, Jun Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888742/ http://dx.doi.org/10.1093/schbul/sby016.499

Ejemplares similares

Effectiveness of antipsychotic drugs in schizophrenia: a 10-year retrospective study in a Korean tertiary hospital
por: Oh, Sanghoon, et al.
Publicado: (2020)

T180. LOWER GLUTAMATE LEVEL IN TEMPORO-PARIETAL AREA MAY PREDICT A BETTER RESPONSE TO TDCS IN SCHIZOPHRENIA: A PILOT STUDY
por: Lee, Junhee, et al.
Publicado: (2018)

PS01. Influence of age of onset on serotonin transporters of obsessive-compulsive
por: Lee, Junhee, et al.
Publicado: (2016)

Pharmacogenetic testing in schizophrenia in real clinical practice: before or after antipsychotic -induced adverse drug reactions development?
por: Abdyrakhmanova, A., et al.
Publicado: (2022)

PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016)

S223. COMBINED TREATMENT WITH A SELECTIVE PDE10A INHIBITOR TAK-063 AND ANTIPSYCHOTICS AT SUBEFFECTIVE DOSES PRODUCES POTENT ANTIPSYCHOTIC-LIKE EFFECTS WITHOUT EXACERBATING SIDE EFFECTS PROFILE IN RODENTS
por: Suzuki, Kazunori, et al.
Publicado: (2018)

Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China
por: Zhang, Lei, et al.
Publicado: (2019)

PM438. Functional connectivity and striatal dopamine synthesis in schizophrenia treated with antipsychotic drugs: multimodal imaging study using [18F]DOPA PET and resting MRI
por: Kim, Euitae, et al.
Publicado: (2016)

Swithching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study
por: Ceres, R., et al.
Publicado: (2023)

PM441. Long term atypical antipsychotic treatment improves cognitive performance in schizophrenia but not surpassing conventional antipsychotic drugs effects.
por: Vera, Gabriel Selva, et al.
Publicado: (2016)

Effect of tDCS on Aberrant Functional Network Connectivity in Refractory Hallucinatory Schizophrenia: A Pilot Study
por: Yoon, Youngwoo Bryan, et al.
Publicado: (2019)

PM510. Temporal relationship of mismatch negativity multiple generators in patients with schizophrenia and subjects at clinical high risk for psychosis
por: Kim, Minah, et al.
Publicado: (2016)

Antipsychotic treatment and cognitive function in patients with schizophrenia
por: Tumova, M. A., et al.
Publicado: (2023)

S235. MAINTENANCE TREATMENT WITH ANTIPSYCHOTIC DRUGS IN SCHIZOPHRENIA – SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

S240. DETERMINANT FACTORS OF REAL-WORLD FUNCTIONING IN SCHIZOPHRENIA
por: González-Blanco, Leticia, et al.
Publicado: (2018)

PT621. Difference of visual spatial dysfunction in drug naïve obsessive compulsive disorder patients in association of untreated duration of illness
por: Kim, Sung Nyun, et al.
Publicado: (2016)

F161. BRAIN VOLUME CHANGE IN PATIENTS WITH SCHIZOPHRENIA AND ITS RELATION WITH ANTIPSYCHOTIC DRUG USE
por: Kiras, Fatma, et al.
Publicado: (2018)

Real‐world effectiveness of antipsychotics
por: Tiihonen, J.
Publicado: (2016)

F223. COMPARATIVE STUDY OF HEART RATE VARIABILITY AND EMOTIONAL RESPONSE TO POSITIVE AND NEGATIVE AUDIOVISUAL STIMULATION IN PATIENTS WITH CHRONIC SCHIZOPHRENIA AND HEALTHY CONTROL
por: Lee, Sang-Yeol, et al.
Publicado: (2018)

T232. EFFICACY AND SAFETY OF ANTIDEPRESSANT AUGMENTATION OF ANTIPSYCHOTICS IN SCHIZOPHRENIA
por: Galling, Britta, et al.
Publicado: (2018)

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
por: Lähteenvuo, M., et al.
Publicado: (2021)

Schizophrenia long-acting antipsychotics initiation index (SLAAII)
por: Ifteni, P., et al.
Publicado: (2021)

Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia
por: Pochiero, Ilena, et al.
Publicado: (2021)

PM461. Inflammation in schizophrenia: Imaging genetics
por: Hwang, Wu Jeong, et al.
Publicado: (2016)

Can We Predict Psychosis Outside the Clinical High-Risk State? A Systematic Review of Non-Psychotic Risk Syndromes for Mental Disorders
por: Lee, Tae Young, et al.
Publicado: (2018)

T192. THE GUT MICROBIOME IN SCHIZOPHRENIA AND ANTIPSYCHOTIC INDUCED METABOLIC DYSFUNCTION
por: Kanji, Sarah, et al.
Publicado: (2018)

Factors associated with real-world functioning in first stages of schizophrenia disorder
por: Martínez-Cao, C., et al.
Publicado: (2021)

F35. PRESCRIPTION PATTERN OF ANTIPSYCHOTICS FOR CHILDREN AND ADOLESCENTS WITH SCHIZOPHRENIA IN KOREA BASED ON NATIONWIDE DATA
por: Park, Kee Jeong, et al.
Publicado: (2018)

O7.3. DOSE-RESPONSE META-ANALYSIS TO IDENTIFY THE OPTIMUM AND EQUIVALENT DOSES OF ANTIPSYCHOTIC DRUGS FOR SCHIZOPHRENIA
por: Leucht, Stefan, et al.
Publicado: (2018)

Characterization of “Responder” in patients with Treatment-Resistant Schizophrenia (TRS) treated with a new antipsychotic added to their current antipsychotic monotherapy
por: Anand, R., et al.
Publicado: (2023)

A Real-World Observation of Antipsychotic Effects on Brain Volumes and Intrinsic Brain Activity in Schizophrenia
por: Chen, Yifan, et al.
Publicado: (2022)

F225. LEVODOPA AUGMENTATION OF ANTIPSYCHOTICS FOR THE TREATMENT OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Foussias, George, et al.
Publicado: (2018)

Which antipsychotics can we use for obsessive-compulsive symptoms in schizophrenia?
por: Aissa, A., et al.
Publicado: (2021)

Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
por: Vasiliu, O.
Publicado: (2022)

Comparative effectiveness of antipsychotic drugs in schizophrenia
por: Stroup, T. Scott, et al.
Publicado: (2000)

The risk of developing diabetes during antipsychotic drug treatment: A nationwide study among 31,856 patients with schizophrenia
por: Marker Madsen, N., et al.
Publicado: (2023)

The relationship between combined antipsychotic use and clinical features in schizophrenia spectrum patients treated in inpatient ward: A retrospective study
por: Baklaci, U.
Publicado: (2021)

PT590. Behavioral and psychological symptoms of dementia and antipsychotic drug use in the elderly with dementia in Korea long-term care facilities
por: Lee, Kang Soo
Publicado: (2016)

13.2 CANNABIDIOL AS AN ANTIPSYCHOTIC DRUG
por: Guimaraes, Francisco, et al.
Publicado: (2018)

PM468. Alterations of structural connectivity in patients with schizophrenia: a systematic review
por: Oh, Hye Rim, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5cfpck17d84v70bkstved9sleb